South Africa now makes critical molecule for lab-grown meat
13 MARCH 2026 | COUNCIL FOR SCIENTIFIC AND INDUSTRIAL RESEARCH |VIDEO
Immobazyme approached the CSIR with a bacterial strain they had genetically modified to produce a commercial protein called fibroblast growth factor 2 (FGF‑2).
This protein gives the signal to mammalian cells to multiply and proliferate, so it is essential for the laboratory-grown meat industry.
The production process of FGF-2 was successfully upscaled at the CSIR with funding from the Technology Innovation Agency.
Immobazyme makes strides to lower cost of cultivated meat
A breakthrough in making lab-grown meat more affordable.
​
Immobazyme is ISO 22000 Certified.
ISO 22000 is a globally recognised food safety management standard. ​
​
Find us on Cellbase
You can now purchase our growth factors on at Cell Bass, The Cultivated Meat B2B Marketplace
​
No Free Lunch with Greg Stewart
Interview with Ethan Hunter discussing Immobazyme's strategic pivot to pharmaceuticals
​
Immobazyme Raises R50 million
Led by the UTF II, with participation from Fireball Capital and USE as co-investors.
​
Don’t Build for Hypothetical Problems
What Immobazyme’s Founders Learned While Dragging University IP Into the Marketplace
​
Cape HealthTech Connect SA's health tech
Entrepreneurs, innovators and researchers gathered to share knowledge and innovations
​
Featured Interview with James Ryall, PhD
Edition #17 - Curing salami, treating hair loss and growing cultivated meat
​
South African Startup of the Year
Immobazyme awarded Biotech Startup of the year at the 2024 Startup Club annual awards
Catalyst 2024 - Startup Competition
Budding biotech entrepreneurs compete in Immobazyme's pitch competition for R350k
Applications for Catalyst 2024 are Open
Catalyst 2024 aims to empower aspiring biotech founders by offering access to viral recourses.
​
Conversations with Global Innovators
Bringing the Biohealth capital region to South Africa: a discussion with 3 groundbreaking geusts
​
Winners of the BiCentrifuge Africa comp
Immobazyme was crowned the Industry category winners of the Bio Centrifuge Africa competition
​
Cultivated, Cell-culture & Biotech
Immobazyme raises $1.3m to boost production of precision fermentation-derived proteins
​
African Biotech Winners, Gains Traction
Interviews with Immobazyme's co-founders on the future of African biotech.​
​
Immobazyme Secures Investment.
Immobazyme has successful secured our next round of funding for a major expansion.
​
Pioneering Biotech for a Better Tomorrow
CEO, Dominic Nicholas stands as a driving force behind Immobazyme.
​
AFYVA interview with founders
Paul Olelle interviews our founders: discussing precision fermentation, our journey and products.
​
Viva Africatech! South African delegation
CEO Immobazyme chosen as the South Africa delegation to attend VivaTech in Paris.
​
Harnessing the Health Benefits of Plants.
Investigating the role of plants in developing new therapeutic compounds.
​
Meet Immobazyme.
Understanding Immobazyme's mission, science and founders.​
​
R26-Million Investment Raised.
Innovus has announced 5 new spinout companies.
​